SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,303,621 | -8.8% | 357,694 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $10,205,010 | -19.0% | 357,694 | -30.1% | 0.00% | 0.0% |
Q2 2022 | $12,602,806 | -76.5% | 511,893 | -46.0% | 0.00% | -75.0% |
Q1 2022 | $53,525,721 | +50.5% | 948,365 | +65.3% | 0.01% | +71.4% |
Q4 2021 | $35,563,000 | +12.9% | 573,781 | +15.6% | 0.01% | 0.0% |
Q3 2021 | $31,488,000 | -27.8% | 496,343 | -6.2% | 0.01% | -22.2% |
Q2 2021 | $43,592,000 | +35.8% | 528,966 | +21.2% | 0.01% | +28.6% |
Q1 2021 | $32,101,000 | -6.0% | 436,335 | -7.4% | 0.01% | -12.5% |
Q4 2020 | $34,156,000 | +187.8% | 470,992 | +89.1% | 0.01% | +166.7% |
Q3 2020 | $11,870,000 | +26.1% | 249,012 | +11.1% | 0.00% | 0.0% |
Q2 2020 | $9,416,000 | +74.4% | 224,200 | +12.1% | 0.00% | +50.0% |
Q1 2020 | $5,400,000 | -29.9% | 200,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $7,698,000 | +77.5% | 200,000 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $4,336,000 | – | 200,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |